8OYP image
Deposition Date 2023-05-05
Release Date 2023-10-18
Last Version Date 2023-11-15
Entry Detail
PDB ID:
8OYP
Keywords:
Title:
Crystal structure of Ubiquitin specific protease 11 (USP11) in complex with a substrate mimetic
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
2.44 Å
R-Value Free:
0.23
R-Value Work:
0.16
R-Value Observed:
0.17
Space Group:
P 21 21 2
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Ubiquitin carboxyl-terminal hydrolase 11,Response regulator FrzS
Gene (Uniprot):USP11, frzS
Mutagens:C318S
Chain IDs:A, B
Chain Length:485
Number of Molecules:2
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Polyubiquitin-B
Gene (Uniprot):UBB
Chain IDs:C, D
Chain Length:79
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CSU A CYS modified residue
Primary Citation
Ubiquitin-specific protease 11 structure in complex with an engineered substrate mimetic reveals a molecular feature for deubiquitination selectivity.
J.Biol.Chem. 299 105300 105300 (2023)
PMID: 37777157 DOI: 10.1016/j.jbc.2023.105300

Abstact

Ubiquitin-specific proteases (USPs) are crucial for controlling cellular proteostasis and signaling pathways but how deubiquitination is selective remains poorly understood, in particular between paralogues. Here, we developed a fusion tag method by mining the Protein Data Bank and trapped USP11, a key regulator of DNA double-strand break repair, in complex with a novel engineered substrate mimetic. Together, this enabled structure determination of USP11 as a Michaelis-like complex that revealed key S1 and S1' binding site interactions with a substrate. Combined mutational, enzymatic, and binding experiments identified Met77 in linear diubiquitin as a significant residue that leads to substrate discrimination. We identified an aspartate "gatekeeper" residue in the S1' site of USP11 as a contributing feature for discriminating against linear diubiquitin. When mutated to a glycine, the corresponding residue in paralog USP15, USP11 acquired elevated activity toward linear diubiquitin in-gel shift assays, but not controls. The reverse mutation in USP15 confirmed that this position confers paralog-specific differences impacting diubiquitin cleavage rates. The results advance our understanding of the molecular basis for the higher selectivity of USP11 compared to USP15 and may aid targeted inhibitor development. Moreover, the reported carrier-based crystallization strategy may be applicable to other challenging targets.

Legend

Protein

Chemical

Disease

Primary Citation of related structures